Christina Mølck

959 total citations
13 papers, 659 citations indexed

About

Christina Mølck is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Christina Mølck has authored 13 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Immunology. Recurrent topics in Christina Mølck's work include Immune Cell Function and Interaction (3 papers), Receptor Mechanisms and Signaling (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Christina Mølck is often cited by papers focused on Immune Cell Function and Interaction (3 papers), Receptor Mechanisms and Signaling (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Christina Mølck collaborates with scholars based in Australia, Denmark and United States. Christina Mølck's co-authors include Gregory D. Stewart, Kevin Sek, Phillip K. Darcy, Paul A. Beavis, Lev M. Kats, Frédéric Hollande, Jean‐Marc Pascussi, Søren Nielsen, Hans Bräuner‐Osborne and David E. Gloriam and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Gut.

In The Last Decade

Christina Mølck

12 papers receiving 653 citations

Peers

Countries citing papers authored by Christina Mølck

Since Specialization

Citations

This map shows the geographic impact of Christina Mølck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Mølck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Mølck more than expected).

Fields of papers citing papers by Christina Mølck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Mølck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Mølck. The network helps show where Christina Mølck may publish in the future.

Co-authorship network of co-authors of Christina Mølck

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Mølck. A scholar is included among the top collaborators of Christina Mølck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Mølck. Christina Mølck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex 2023 ·SHILAP Revista de lepidopterología ·Maxim A. X. Tollenaere, Christina Mølck, Ian Henderson, Scott J. Pollack, (unknown), H. Petersen, Hanne Norsgaard	12
2	Longitudinal Monitoring of Intra-Tumoural Heterogeneity Using Optical Barcoding of Patient-Derived Colorectal Tumour Models 2022 ·Cancers ·(unknown), Jai Smith, (unknown), (unknown), Hyun‐Jung Cho, Christina Mølck, Corina Behrenbruch, Benjamin Thomson, Alexander G. Heriot, Delphine Mérino, Frédéric Hollande	6
3	CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy 2021 ·Nature Communications ·Lauren Giuffrida, Kevin Sek, Melissa A. Henderson, Junyun Lai, Amanda X. Y. Chen, Déborah Meyran, Kirsten L. Todd, Emma V. Petley, Sherly Mardiana, Christina Mølck, Gregory D. Stewart, Benjamin Solomon, Ian A. Parish, Paul J. Neeson, Simon J. Harrison, Lev M. Kats, Imran G. House, Phillip K. Darcy, Paul A. Beavis	150
4	Fragment-Based Discovery of Pyrazolopyridones as JAK1 Inhibitors with Excellent Subtype Selectivity 2020 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Mogens Larsen, (unknown), (unknown), (unknown), Jens Larsen, (unknown), (unknown), (unknown), Christina Mølck, Paola Lovato, (unknown), (unknown), Andreas Ritzén	22
5	A Spatio-Temporal Model and Inference Tools for Longitudinal Count Data on Multicolor Cell Growth 2018 ·The International Journal of Biostatistics ·(unknown), Christina Mølck, Davide Ferrari, Frédéric Hollande	0
6	Surgical stress response and promotion of metastasis in colorectal cancer: a complex and heterogeneous process 2018 ·Clinical & Experimental Metastasis ·Corina Behrenbruch, (unknown), Sophie Paquet‐Fifield, Christina Mølck, Hyun‐Jung Cho, Michael Michael, Benjamin Thomson, Alexander G. Heriot, Frédéric Hollande	51
7	Targeting Adenosine Receptor Signaling in Cancer Immunotherapy 2018 ·International Journal of Molecular Sciences ·Kevin Sek, Christina Mølck, Gregory D. Stewart, Lev M. Kats, Phillip K. Darcy, Paul A. Beavis	144
8	Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture 2016 ·Gut ·Fanny Grillet, (unknown), (unknown), Luke Zappia, Ebba L. Lagerqvist, Sebastian Lunke, Emmanuelle Charafe‐Jauffret, Kym Pham, Christina Mølck, (unknown), (unknown), Michel Prudhomme, Claire Philippe, (unknown), (unknown), Lucile Canterel-Thouennon, (unknown), Arthur Hsu, Jean‐Marc Pascussi, Frédéric Hollande, Julie Pannequin	159
9	The A 2b adenosine receptor antagonist PSB-603 promotes oxidative phosphorylation and ROS production in colorectal cancer cells via adenosine receptor-independent mechanism 2016 ·Cancer Letters ·Christina Mølck, James G. Ryall, (unknown), (unknown), Jean‐Marc Pascussi, Joan K. Heath, Gregory D. Stewart, Frédéric Hollande	26
10	High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cells 2016 ·Oncotarget ·(unknown), (unknown), Christina Mølck, Sophie Paquet‐Fifield, Lisa M. Butler, Erica K. Sloan, Sabatino Ventura, Frédéric Hollande	16
11	mGluR5: Exploration of Orthosteric and Allosteric Ligand Binding Pockets and Their Applications to Drug Discovery 2014 ·Neurochemical Research ·Christina Mølck, Kasper Harpsøe, David E. Gloriam, Jesper Mosolff Mathiesen, Søren Nielsen, Hans Bräuner‐Osborne	26
12	Structure–Activity Relationships for Negative Allosteric mGluR5 Modulators 2012 ·ChemMedChem ·(unknown), Kasper Harpsøe, (unknown), Jesper Mosolff Mathiesen, Christina Mølck, David E. Gloriam, (unknown), Michelle A. Uberti, Søren Nielsen, Birgitte Nielsen, Hans Bräuner‐Osborne, Per Sauerberg, Rasmus P. Clausen, Ulf Madsen	16
13	Pharmacological Characterization and Modeling of the Binding Sites of Novel 1,3-Bis(pyridinylethynyl)benzenes as Metabotropic Glutamate Receptor 5-Selective Negative Allosteric Modulators 2012 ·Molecular Pharmacology ·Christina Mølck, Kasper Harpsøe, David E. Gloriam, Rasmus P. Clausen, Ulf Madsen, Lars Østergaard Pedersen, (unknown), Søren Nielsen, Jesper Mosolff Mathiesen, Hans Bräuner‐Osborne	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact